lobbying_activities: 1527576
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1527576 | 2403f9af-befb-43f2-aa95-e4e37bf37c09 | Q1 | GSK (FKA GLAXOSMITHKLINE INC.) | 16293 | GSK (FKA GLAXOSMITHKLINE INC.) | 2014 | first_quarter | HCR | H.R. 1248 - Family Health Care Flexibility Act, provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts H.R. 3204 - Drug Quality and Security Act, provisions relating to pharmacy compounding and supply chain H.R. 3742 - Antibiotic Development to Advance Patient Treatment ActH.R. 4260 - Ryan White Patient Equity and Choice Act, provisions related to ADAP S. 610 - Family Health Care Flexibility Act, provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts S. 957 - Drug Supply Chain Security Act, provisions related to supply chain security S. 959 - Pharmaceutical Compounding Quality and Accountability Act, provisions related to pharmaceutical compounding S. 1165 - Access to Appropriate Immunizations for Veterans Act of 2013, provisions related to extending VA performance measure to include all federally recommended vaccine No bill # assigned - Implementation issues relating to the Patient Protection and Affordable Care Act (PPACA) (Public Law 111-148), including Standards Related to Essential Health Benefits, Actuarial Value, and Accreditation rulemaking No bill # assigned - FDA special medical use, issues related to limited population antibacterial drug approval pathway No bill # assigned - FDA accelerated approval policy issues No bill # assigned - Comparative effectiveness policy issues No bill # assigned - Biopharmaceutical innovation policy issues No bill # assigned - Pharmaceutical supply chain security issues No bill # assigned - 340B policy issues No bill # assigned - Implementation issues relating to the Physician Payment Sunshine Act | Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR) | 1630000 | 0 | 0 | 2014-04-18T14:11:03.963000-04:00 |